KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Evolent Health (EVH) Receivables - Other (2016 - 2021)

Evolent Health has reported Receivables - Other over the past 7 years, most recently at $190000.0 for Q1 2021.

  • Quarterly results put Receivables - Other at $190000.0 for Q1 2021, down 89.16% from a year ago — trailing twelve months through Mar 2021 was $190000.0 (down 89.16% YoY), and the annual figure for FY2020 was $329000.0, down 81.21%.
  • Receivables - Other for Q1 2021 was $190000.0 at Evolent Health, down from $329000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for EVH hit a ceiling of $10.1 million in Q3 2019 and a floor of $190000.0 in Q1 2021.
  • Median Receivables - Other over the past 5 years was $4.1 million (2017), compared with a mean of $4.3 million.
  • Biggest five-year swings in Receivables - Other: surged 112.63% in 2019 and later tumbled 93.33% in 2020.
  • Evolent Health's Receivables - Other stood at $3.4 million in 2017, then plummeted by 37.4% to $2.1 million in 2018, then fell by 16.7% to $1.8 million in 2019, then plummeted by 81.21% to $329000.0 in 2020, then plummeted by 42.25% to $190000.0 in 2021.
  • The last three reported values for Receivables - Other were $190000.0 (Q1 2021), $329000.0 (Q4 2020), and $671000.0 (Q3 2020) per Business Quant data.